Результати пошуку - Igor Espinoza‐Delgado
- Показ 1 - 20 результатів із 20
-
1
Clinical Toxicities of Histone Deacetylase Inhibitors за авторством Srividya Subramanian, Susan E. Bates, James R. Wright, Igor Espinoza‐Delgado, Richard Piekarz
Опубліковано 2010Revisão -
2
-
3
-
4
Expression and role of p75 interleukin 2 receptor on human monocytes. за авторством Igor Espinoza‐Delgado, John R. Ortaldo, Robin Winkler-Pickett, Kazuo Sugamura, Luigi Varesio, D L Longo
Опубліковано 1990Artigo -
5
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma за авторством Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Paul Frankel, Barbara J. Gitlitz, Marianna Koczywas, Igor Espinoza‐Delgado, David R. Gandara
Опубліковано 2009Artigo -
6
A phase 2 study of vorinostat in acute myeloid leukemia за авторством Élise Schaefer, Arturo Loaiza‐Bonilla, Mark Juckett, John F. DiPersio, Vivek Roy, James L. Slack, Wenting Wu, K. M. Laumann, Igor Espinoza‐Delgado, S. D. Gore
Опубліковано 2009Artigo -
7
Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer за авторством Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel, Athanassios Argiris, Marianna Koczywas, Barbara J. Gitlitz, Sachdev Thomas, Igor Espinoza‐Delgado, Everett E. Vokes, David R. Gandara, Chandra P. Belani
Опубліковано 2009Artigo -
8
A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer за авторством Marwan Fakih, Lakshmi Pendyala, Gerald J. Fetterly, K. Toth, James A. Zwiebel, Igor Espinoza‐Delgado, Alan Litwin, Youcef M. Rustum, Mary Ellen Ross, Julianne L. Holleran, Merrill J. Egorin
Опубліковано 2009Artigo -
9
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors за авторством Giuseppe Giaccone, Arun Rajan, Arlene Berman, Ronan J. Kelly, Éva Szabó, Ariel López-Chávez, Jane B. Trepel, Min-Jung Lee, Liang Cao, Igor Espinoza‐Delgado, John Spittler, Patrick J. Loehrer
Опубліковано 2011Artigo -
10
Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid... за авторством Ivana Gojo, Ming Tan, Hong‐Bin Fang, Mariola Sadowska, Rena G. Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rahul Srivastava, Igor Espinoza‐Delgado, Douglas D. Ross
Опубліковано 2013Artigo -
11
Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma за авторством Mark Kirschbaum, Paul Frankel, Leslie Popplewell, Jasmine Zain, Maria Delioukina, Vinod Pullarkat, Deron Matsuoka, Bernadette Pulone, A Rotter, Igor Espinoza‐Delgado, Auayporn Nademanee, Stephen J. Forman, David R. Gandara, Edward M. Newman
Опубліковано 2011Artigo -
12
Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study за авторством Anne M. Traynor, Sarita Dubey, Jens C. Eickhoff, Jill Kolesar, Kathleen Schell, Michael S. Huie, David L. Groteluschen, Sarah M. Marcotte, Courtney M. Hallahan, Hilary Weeks, George Wilding, Igor Espinoza‐Delgado, Joan H. Schiller
Опубліковано 2009Artigo -
13
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916) за авторством Jodi A. Muscal, Patrick A. Thompson, Terzah M. Horton, Ashish M. Ingle, Charlotte H. Ahern, Renee M. McGovern, Joel M. Reid, Matthew M. Ames, Igor Espinoza‐Delgado, Brenda J. Weigel, Susan M. Blaney
Опубліковано 2012Artigo -
14
Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma за авторством Ashraf Badros, Angelika M. Burger, Sunita Philip, Rubén Niesvizky, Sarah Kolla, Olga Goloubeva, Carolynn Harris, James A. Zwiebel, James R. Wright, Igor Espinoza‐Delgado, Maria R. Baer, Julianne L. Holleran, Merrill J. Egorin, Steven Grant
Опубліковано 2009Artigo -
15
Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo за авторством B Ramaswamy, Warren Fiskus, Barbara Cohen, C. Pellegrino, Dawn L. Hershman, Ellen Chuang, Thehang Luu, George Somlo, Matthew P. Goetz, Ramona F. Swaby, Charles L. Shapiro, Vered Stearns, PJ Christos, Igor Espinoza‐Delgado, Kapil N. Bhalla, Joseph A. Sparano
Опубліковано 2011Artigo -
16
Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas за авторством Anastasios Stathis, Sébastien J. Hotte, Eric X. Chen, Holger W. Hirte, Amit M. Oza, Patrícia Moretto, Sheila Webster, Anne Laughlin, Lee-Anne Stayner, Shauna McGill, Lisa Wang, Wenjiang Zhang, Igor Espinoza‐Delgado, Julianne L. Holleran, Merrill J. Egorin, Lillian L. Siu
Опубліковано 2011Artigo -
17
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer за авторством Rosalyn A. Juergens, John Wrangle, Frank P. Vendetti, Sara C. Murphy, Ming Zhao, Barbara Coleman, Rosa Sebree, Kristen Rodgers, Craig M. Hooker, Noreli Franco, Beverly Lee, Salina Tsai, Igor Espinoza Delgado, Michelle A. Rudek, Steven A. Belinsky, James G. Herman, Stephen B. Baylin, Malcolm V. Brock, Charles M. Rudin
Опубліковано 2011Artigo -
18
Summary Statement Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference Assessing Opportunities for Combination Therapy за авторством Thomas J. Lynch, George R. Blumenschein, Jeffrey A. Engelman, Igor Espinoza‐Delgado, Ramaswamy Govindan, Jeff Hanke, Nasser H. Hanna, John V. Heymach, Fred R. Hirsch, Pasi A. Jänne, Rogério Lilenbaum, Ronald B. Natale, Gregory J. Riely, Lecia V. Sequist, Geoffrey I. Shapiro, Alice T. Shaw, Frances A. Shepherd, Mark A. Socinski, A. Gregory Sorensen, Heather A. Wakelee, Aaron Weitzman
Опубліковано 2008Artigo -
19
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies за авторством Tamer E. Fandy, James G. Herman, Patrick Kerns, Anchalee Jiemjit, Elizabeth A. Sugar, Si-Ho Choi, Allen S. Yang, Timothy Aucott, Tianna Dauses, Rosalie Odchimar-Reissig, Jonathan D. Licht, Melanie J. McConnell, Chris A. Nasrallah, Marianne K. H. Kim, Weijia Zhang, Yezou Sun, Anthony J. Murgo, Igor Espinoza‐Delgado, Katharine Oteiza, Ibitayo Owoeye, Lewis R. Silverman, Steven D. Gore, Hetty E. Carraway
Опубліковано 2009Artigo -
20
Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03 за авторством Eudocia Q. Lee, Vinay K. Puduvalli, Joel M. Reid, John G. Kuhn, Kathleen R. Lamborn, Timothy F. Cloughesy, Susan M. Chang, Jan Drappatz, W. K. Alfred Yung, Mark R. Gilbert, H. Ian Robins, Frank S. Lieberman, Andrew B. Lassman, Renee M. McGovern, Jihong Xu, Serena Desideri, Xiabu Ye, Matthew M. Ames, Igor Espinoza‐Delgado, Michael D. Prados, Patrick Y. Wen
Опубліковано 2012Artigo
Інструменти для пошуку:
Пов'язані теми
Internal medicine
Medicine
Gene
Oncology
Biochemistry
Biology
Histone
Histone deacetylase
Gastroenterology
Vorinostat
Chemistry
Pharmacology
Chemotherapy
Adverse effect
Cancer
Lung cancer
Pharmacokinetics
Surgery
Toxicity
Astrobiology
Cancer research
Cell biology
DNA methylation
Epigenetics
Gene expression
Histone deacetylase inhibitor
Immunology
Molecular biology
Monocyte
Neutropenia